A Closer Look at Global Health Research and Development

By HEOR Staff Writer

December 29, 2023

Advancing Health Research on a Global Scale

Global Observatory on Health Research and Development (R&D) of the World Health Organisation (WHO) has just debuted its most current results. The report’s depiction of severe inequalities in the allocation of resources, money, and capacity for global health research was not unexpected. There is obviously a divide between nations with high incomes and those with low or medium incomes. The publication of this finding in the journal Health Research Policy and Systems highlights the importance of thoroughly reevaluating strategies and financial decisions for health research and development.

The Critical Need to Resolve Past Inequities

The recent COVID-19 pandemic and other outbreaks such as mpox underscore the urgent need for a fairer allocation of health research funds. Despite numerous discussions and proposals, the disparity in resource distribution between wealthy and poor nations remains largely unaddressed. This issue is critical not only for disaster preparedness but also for the global goal of improving population health equitably.

Important Results from the Worldwide Health Research and Development Project

The report highlighted four major issues. In 2020, low-income nations received just 0.2% of all grant funding, highlighting the huge disparity in this area. As a second point, the disparity in research capacity is exacerbated by the fact that high-income nations have around 56 times more health researchers per million resident than low-income countries. Third, there is a dearth of research training possibilities in low-income nations due to the low density of higher education institutions relative to the population. Finally, the suggested goals for health R&D spending as a proportion of GDP were unmet by a number of nations.

The Need to Take Action

Consistent gaps in health research capacity and financing are highlighted by the results. There has been no improvement in decades of acknowledgment. The paper recommends a systematic approach to data collection and prioritises research. It promotes frequent data exchange and advocates for global collaboration in solving these problems.

The Global Observatory on Health Research and Development remains a vital tool today. It monitors and analyses data on health research and development. It highlights both the opportunities and challenges in this crucial sector. If the international community collaborates to bridge the knowledge gap, we can improve health outcomes for all. 

Reference url

Recent Posts

Enhertu Breast Cancer Treatment Gains FDA Approval in Neoadjuvant and Adjuvant Settings

By João L. Carapinha

May 18, 2026

Enhertu breast cancer treatment has secured FDA approval for neoadjuvant use in adults with HER2-positive Stage II or III disease before surgery, followed by taxane plus trastuzumab and pertuzumab, and for adjuvant therapy in patients with residual invasive disease after prior trastuzumab-based r...
Pharmaceutical Onshoring Agreements: Navigating Tariff Relief and National Security Policies
The US Bureau of Industry and Security published formal procedures enabling manufacturers of patented pharmaceutical products to apply for company-specific pharmaceutical onshoring agreements with the Department of Commerce. These agreements allow qualifying firms to secure a reduced Section 232 ...
Core Recommendations for Equitable Digital Medicine Access
Ensuring equitable digital medicine access stands as a central goal of the Council of Europe’s latest guidance on remote pharmaceutical services. The CM...